Benchmarking
Market ComparisonApr 2026
Among small-tier medical markets, Georgia stands out for the sharpest disconnect between retail expansion and sales performance. Dispensary count nearly quadrupled year over year to 19 locations, yet sales contracted 41.6% and have fallen 43.1% over two years. Few peer markets have added stores at that pace while watching revenue shrink, a signal that Georgia's restrictive product scope—limited to low-THC oil—constrains demand regardless of how many dispensaries open.
24-Month Trend

| State | Sales | YoY |
|---|---|---|
| New Hampshire | $.5M-1M | 19.8% |
| Texas | $.5M-1M | 105.3% |
| Nunavut | $250-500K | 57.9% |
| Georgia | $250-500K | 41.6% |
| Yukon | $<250K | 4.5% |
Benchmarking
Market ComparisonApr 2026
Among small-tier medical markets, Georgia stands out for the sharpest disconnect between retail expansion and sales performance. Dispensary count nearly quadrupled year over year to 19 locations, yet sales contracted 41.6% and have fallen 43.1% over two years. Few peer markets have added stores at that pace while watching revenue shrink, a signal that Georgia's restrictive product scope—limited to low-THC oil—constrains demand regardless of how many dispensaries open.
24-Month Trend

| State | Sales | YoY |
|---|---|---|
| New Hampshire | $.5M-1M | -19.8% |
| Texas | $.5M-1M | +105.3% |
| Nunavut | $250-500K | -57.9% |
| Georgia | $250-500K | -41.6% |
| Yukon | $<250K | -4.5% |